Targeting Oncogenic Driver Mutations in Lung Cancer

Cambridge University Press
SKU:
9781009336130
|
UPC:
9781009336130
£17.78
(No reviews yet)
Condition:
New
Current Stock:
Adding to cart… The item has been added
This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.


  • | : Matthew Lee (Montefiore Medical Center and Albert Einstein College of Medicine), Fawzi Abu Rous (Henry Ford Health System), Alain Borczuk (Weill Cornell Medicine), Stephen Liu (Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC), Shirish Gadgeel (Henry Ford Health System), Balazs Halmos (Montefiore Medical Center and Albert Einstein College of Medicine)
  • | Publisher: Cambridge University Press
  • | Publication Date: Feb 02, 2023
  • | Country of Publication: United Kingdom
  • | Number of Pages: 75 pages
  • | Language: Unknown
  • | Binding: Paperback / softback
  • | ISBN-10: 1009336134
  • | ISBN-13: 9781009336130
By (Author):
Matthew Lee (Montefiore Medical Center and Albert Einstein College of Medicine), Fawzi Abu Rous (Henry Ford Health System), Alain Borczuk (Weill Cornell Medicine), Stephen Liu (Lombardi Comprehensive Cancer Center, Georgetown University, Washington D
Publisher:
Cambridge University Press
Publication Date:
Feb 02, 2023
Country of Publication:
United Kingdom
Language:
Unknown
Number of pages:
75 pages
Binding:
Paperback / softback
ISBN-10:
1009336134
ISBN-13:
9781009336130